Imagine you have a toy store, and you have a box of toys you want to sell. These toys are worth a lot of money, and if you sell them, you will make a big profit. But first, you need to tell people about your toys.

So you go to a nearby town and tell people about your toy store. You tell them how many toys you have, how much they are worth, and how much they can sell for. You also tell them how much it will cost to buy the toys from you.

Some people in the town get excited about your toys and decide to buy some from you. They pay you the money you told them, and you give them the toys. You make a lot of money, and they get some cool toys.

But what if the people in the town tell other people about your toys? What if they tell their friends and family about how great your toys are and how much money they can make from them?

If this happens, even more people will come to your toy store to buy toys. You will make even more money, and the people who told others about your toys will get a little bit of money too.

This is what happens when a company's stock price goes up. If a company does well and tells people about its success, more people will want to buy its stock. This will make the stock price go up, and everyone who owns the stock will make money. Read from source...

"This isn't fair, he wouldn't treat my mom like that!" or "This is ridiculous, I know how he got his ideas." The second part of the narrative was often about what happened after the publication, such as the author being ridiculed on social media, receiving death threats or being targeted by those who disagreed with the author's perspective.

NEUTRAL

### BZ:

# Is Jazz Pharmaceuticals Stock Undervalued Right Now?

Written by Zacks, Benzinga Contributor on October 1, 2024

At Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.

Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.

One company to watch right now is Jazz Pharmaceuticals JAZZ. JAZZ is currently sporting a Zacks Rank of #2 (Buy) and an A for Value.

Investors should also note that JAZZ holds a PEG ratio of 1.05. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. JAZZ's PEG compares to its industry's average PEG of 2.21. JAZZ's PEG has been as high as 1.44 and as low as 0.64, with a median of 1.05, all within the past year.

Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's sales. This is a popular metric because sales are harder to manipulate on an income statement, so they are often considered a better performance indicator. JAZZ has a P/S ratio of 1.76. This compares to its industry's average P/S of 3.11.

Finally, investors will want to recognize that JAZZ has a P/CF ratio of 5.74. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. JAZZ's P/CF compares to its industry's average P/CF of 11.35. Over the past year, JAZZ's P/CF has been as high as 43.45

$0
- Access to every tool and resource
- Access to expert insights and research articles
- Virtual access to your portfolio anytime, anywhere
- Investment bank quality data and analytics
- Detailed financial statements, news, and document filings
- Full access to Stansberry's esteemed weekly report
- An exclusive look at Stansberry’s premium trading service

"The One About My Case" presented by Postmates

These are the myriad ways the Sex and the City gang stays connected.

By signing up you agree to our user agreement and privacy policy.
You also accept use of cookies and similar technologies, targeted ads and data sales.

I agree to the Postmedia's Terms of Use and acknowledge that I have read the Privacy Statement.

### Submit a letter to the editor

New and innovative methods of blood pressure monitoring show promise.

One startup to watch in the health tech space is BioT<|im_start|> Inc., a telemedicine company specializing in continuous remote health monitoring. The company's innovative wearable medical device, the BioTeg SensorPatch, is specifically designed to help people monitor their blood pressure without needing to visit a doctor or use a traditional arm cuff.

Blood pressure monitors are an essential tool for managing high blood pressure and reducing the risk of heart disease. However, conventional monitors, like arm cuffs, can be inconvenient and difficult for many people to use. This can lead to a lack of regular monitoring, which can be detrimental to one's health.

The BioTeg SensorPatch is a small, lightweight, and wearable adhesive patch that can be applied to the chest. The patch contains sensors that collect physiological data, including blood pressure, ECG, respiratory rate, body temperature, and movement. This data is then transmitted wirelessly to a mobile device, allowing users to track their blood pressure and other health metrics in real-time.

The company claims that the SensorPatch is highly accurate and can detect subtle changes in blood pressure over time, making it an ideal tool for managing high blood pressure. The device is also easy to use, making it accessible to a wide range of people, including those with limited mobility or dexterity.

In addition to the SensorPatch, BioTeg is developing a range of other remote health monitoring devices, including wearable patches for measuring glucose levels and implantable sensors for monitoring brain activity. These devices could revolutionize the way we manage and track our health, enabling people to take a more proactive approach to their well-being.

With the growing demand for remote health monitoring and the increasing prevalence of chronic conditions like high blood pressure, companies like BioTeg are poised to make a significant impact on the health tech industry. By